Maternal and fetal outcomes in placenta increta managed by a multidisciplinary care team.
WANG Xiao-yi,SUN Wen, LI Zhi-hua, ZHOU Yan-mei, XIAO Xue,YU Lin, LIN Lin, SU Chun-hong, CHEN Dun-jin.
Chinese Journal of Practical Gynecology and Obstetrics ›› 2015, Vol. 31 ›› Issue (5) : 445-448.
Maternal and fetal outcomes in placenta increta managed by a multidisciplinary care team.
Abstract： Objective To investigate maternal and fetal outcomes in placenta increta managed by a multidisciplinary care team. Methods A retrospective study was performed in 81 cases of placenta increta between January 2005 and January 2014 in the Third Affiliated Hospital of Guangzhou Medical University．The women were divided into multidisciplinary care team group in whole process，multidisciplinary care team group in the stage of delivery and standard obstetric care team group. The maternal and fetal outcomes in placenta accreta was evaluated.Results The blood loss［（1453.2±991.2）mL and (1536.4±1001.3）］mL，packed red blood cells (pRBCs) transfusion［（592.1±301.2 ）mL and (632.4±279.8）mL］ and early composite morbidity［26.5%（9/34） and 31.8%（7/22）］ in multidisciplinary care team group in whole process and multidisciplinary care team group in the stage of delivery were lower than standard obstetric care team group［(1889.3±1403.4) mL、(721.4±298.1) mL and 60.0%（15/25）］（P＜0.05）. Conclusion multidisciplinary care team management can improve maternal outcomes of placenta increta, but not neonatal ones.
placenta increta / postpartum hemorrhage / multidisciplinary care team / maternal and fetal outcomes
［1］ Publications Committee, Society for Maternal-Fetal Medicine, Belfort MA. Placenta accreta［J］. Am J Obstet Gynecol， 2010,203(5):430-439.
［2］ Eller AG, Bennett MA, Sharshiner M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisiplinary care team compared with standard obstetric care［J］. Obstet Gynaecol，2011,117(2 Pt 1):331-337.
［3］ 陈敦金. 胎盘植入［M］. 长沙：湖南科学技术出版社，2013:3-17.
［4］ 谢幸,苟文丽.妇产科学［M］.8版.北京：人民卫生出版社,2013:212-214.
［5］ Committee on Obstetric Practice. Committee opinion no. 529: placenta accreta［J］. Obstet Gynecol， 2012,120(1):207-211.
［6］ Tam KB, Dozier J, Martin JN Jr. Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: a systematic review［J］. J Matern Fetal Neonatal Med， 2012,25(4):329-334.
［7］ Garmi G, Salim R. Epidemiology, etiology, diagnosis, and management of placenta accreta［J］. Obstet Gynecol Int， 2012,2012:873929.
［8］ Wright JD, Herzog TJ, Shah M, et al. Regionalization of care for obstetric hemorrhage and its effect on maternal mortality［J］. Obstet Gynecol 2010,115(6):1194-1200.
［9］ Rath W, Hackethal A, Bohlmann MK. Second-line treatment of postpartum haemorrhage (PPH) ［J］. Arch Gynecol Obstet,2012,286(3):549-561.
［10］ Shamsa A, Harris A, Anpalagan A. Peripartum hysterectomy in a tertiary hospital in Western Sydney［J］. J Obstet Gynaecol，2014,29: 1-4.
［11］ Bauer ST, Bonanno C. Abnormal placentation［J］. Semin Perinatol 2009,33(2):88-96.
［12］ Eller AG, Porter TF, Soisson P,et al. Optimal management strategies for placenta accreta［J］. BJOG，2009,116(5):648-654.
［13］ Rosen T. Placenta accreta and cesarean scar pregnancy: overlooked costs of the rising cesarean section rate［J］. Clin Perinatol，2008,35(3):519-529,x.
［14］ Al-Khan A, Gupta V, Illsley NP, et al.Maternal and fetal outcomes in placenta accreta after institution of team-managed care［J］.Reprod Sci， 2014,21(6):761-771.
（2014-12-01 收稿 2015-02-08 修回）
/
| 〈 |
|
〉 |
